v3.22.4
Statement of Consolidated Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Operating Activities      
Net loss $ (181) $ (397) $ (109)
Adjustments to reconcile net loss to cash provided from (used for) operations:      
Depreciation and amortization 237 253 251
Goodwill, Impairment Loss 0 65 0
Deferred income taxes (45) (100) (16)
Restructuring and other charges 456 624 188
Net periodic pension benefit cost 81 68 82
Stock-based compensation 15 22 23
Amortization of debt issuance costs 5 5 25
Other 4 16 (1)
Changes in assets and liabilities, excluding effects of acquisitions, divestitures, and foreign currency translation adjustments:      
Decrease (Increase) in receivables 34 (381) (235)
(Increase) Decrease in inventories (149) (596) 65
(Increase) in prepaid expenses and other current assets (80) (1) (16)
(Decrease) Increase in accounts payable, trade (67) 581 82
Increase (Decrease) in accrued expenses 38 (129) (217)
Increase in taxes, including income taxes 2 21 99
Pension contributions (31) (458) (271)
(Increase) Decrease in noncurrent assets (6) (8) 35
Increase in noncurrent liabilities 25 8 21
Cash provided from (used for) operations 338 (407) 6
Financing Activities      
Net transfers from former parent company 0 0 216
Separation payment to former parent company   0 (728)
Additions to debt (original maturities greater than three months) 0 319 2,400
Debt issuance costs (1) (5) (57)
Payments on debt (original maturities greater than three months) 0 0 (1,100)
Other (10) (18) 13
Cash (used for) provided from financing activities (196) 135 744
Investing Activities      
Capital expenditures (245) (184) (163)
Proceeds from the sale of assets and businesses (30) (1) (125)
Payments for (Proceeds from) Other Investing Activities 1 4 0
Cash used for investing activities (214) (181) (38)
Effect of exchange rate changes on cash and cash equivalents and restricted cash (2) 1 3
Net change in cash and cash equivalents and restricted cash (74) (452) 715
Cash and cash equivalents and restricted cash at beginning of year 335 787 72
Cash and cash equivalents and restricted cash at end of year 261 335 787
Payments for Repurchase of Common Stock $ (185) $ (161) $ 0